Insuman Basal GT: description, release forms and application
Insuman Basal GT is a drug from the group of intermediate-acting insulins. It is produced in Germany by the companies Aventis Pharma Deutschland GmbH and Hoechst Marion Roussel GmbH, and its international name is Insulin-isophane (human genetically engineered).
The drug is available in several dosage forms: suspension for injection 100IU/ml, suspension for injection 100IU/ml, suspension for injection 40IU/ml and suspension for injection 40IU/ml. These different forms allow you to customize the dosage of the drug depending on the patient's needs.
Insuman Basal GT contains insulin, which is a natural hormone produced by the pancreas. The drug helps lower blood sugar levels and is used to treat diabetes.
The average period of action of Insuman Basal GT is about 12 hours. However, like other intermediate-acting insulins, the effect of the drug can last up to 24 hours.
The drug is often used in combination with other insulins, such as short-acting insulins, to achieve adequate blood sugar control in patients with diabetes.
Insuman Basal HT may have side effects such as hypoglycemia (blood sugar levels too low), allergic reactions and problems with the injection site. Therefore, before starting to use the drug, it is important to consult a doctor and strictly follow the dosage recommendations.
In conclusion, Insuman Basal GT is a drug from the group of intermediate-acting insulins that is used to treat diabetes. It is available in several dosage forms and is often used in combination with other insulins to achieve desired blood sugar control. However, like any other drug, Insuman Basal GT should be used only as prescribed by a doctor and strictly follow the dosage recommendations.